Demeestere Isabelle, Simon Philippe, Englert Yvon, Delbaere Anne
Research Laboratory on Human Reproduction; Fertility Clinic, Free University of Brussels, Erasme Hospital, 808 Route de Lennik, 1070 Brussels, Belgium.
Reprod Biomed Online. 2003 Nov;7(5):572-9. doi: 10.1016/s1472-6483(10)62074-3.
Chemotherapy and radiotherapy induce premature ovarian failure in many patients treated for oncological or benign diseases. The present paper reviews the risk of developing premature ovarian failure according to the type of treatment and the different options to preserve fertility, focusing on the cryopreservation of ovarian tissue. This technique constitutes a promising approach to preserve the fertility of young patients and offers the advantage of storing a large number of follicles that could be subsequently transplanted or cultured in vitro to obtain mature oocytes. Based on 34 requests, from which 19 were performed, the feasibility of the ovarian cryopreservation procedure is evaluated. The medical and ethical approaches of this protocol are also discussed. Cryopreservation of ovarian tissue constitutes new hope for many patients, but must still be kept for selected cases, with a significant risk of premature ovarian failure after treatments such as bone marrow transplantation.
化疗和放疗会使许多接受肿瘤或良性疾病治疗的患者出现卵巢早衰。本文根据治疗类型和不同的生育力保存选择,综述了发生卵巢早衰的风险,重点关注卵巢组织冷冻保存。这项技术是一种很有前景的保存年轻患者生育力的方法,具有储存大量卵泡的优势,这些卵泡随后可进行移植或体外培养以获得成熟卵母细胞。基于34例申请(其中19例已实施),对卵巢冷冻保存程序的可行性进行了评估。还讨论了该方案的医学和伦理方法。卵巢组织冷冻保存为许多患者带来了新希望,但仍应仅用于特定病例,因为在诸如骨髓移植等治疗后存在卵巢早衰的重大风险。